Associate Professor; Neuro-Oncology Clinical Research Team Leader, Medical Oncology
Nicholas A. Blondin, MD, is an Associate Professor of Neurology at Yale School of Medicine. Dr. Blondin cares for patients at Smilow Cancer Hospital in New Haven and the Smilow Cancer Hospital Cancer Care Center in Trumbull. He received his Medical Degree from the University of Connecticut School of Medicine and completed his neurology residency at Yale New Haven Hospital, where he was Chief Resident in Neurology, followed by a fellowship in Neuro-Oncology at Yale New Haven Hospital. Before joining Smilow, he was the Director of the Neuro-Oncology Program at Associated Neurologists of Southern CT and the Medical Director of the St. Vincent’s Brain Tumor Center. Watch a video with Dr. Nicholas Blondin>> Dr. Blondin’s clinical expertise is in treating benign and malignant brain tumors, brain and spine metastasis, and neurological symptoms of cancer, such as seizures, cognitive impairment, headaches, gait disturbance, and weakness. He has a particular interest in treating glioblastoma, IDH-mutant glioma, and leptomeningeal metastasis of cancer. Dr. Blondin is the leader of the Neuro-Oncology Clinical Research Team, and serves as Principal Investigator of clinical trials at Yale and nationally. He is a member of the Developmental Therapeutics section of the Yale Cancer Center. He also is a member of the Yale Biomedical Imaging Institute and is the Clinical Principal Investigator for studies of Deuterium Metabolic Imaging of brain tumors.